#UTI amc in focus
#Q3Results #Q3FY25 

3% overall and flat equity AUM growth qoq. UTI has seen sequentially better flows, which have offset some of the MTM weakness.

Strong core PBT growth of ~65% yoy, led by ~30% revenue growth and 9% expense growth. Expect focus on ways to drive stronger flows in MF business.